Next Article in Journal
An Improved Synthesis of 7, 8-Epoxy-1,3,11-cembratriene-15R(α), 16-diol, a Cembranoid of Marine Origin with a Potent Cancer Chemopreventive Activity
Previous Article in Journal
Effects of Polybrominated Diphenol Ethers from a Marine Sponge Phyllospongia dendyi on IL-8 Production in a PMAstimulated Promyelocytic Leukemia Cell Line
Article Menu

Export Article

Marine Drugs 2005, 3(4), 126-126; doi:10.3390/md304126

Farewell Address of Marine Drugs Executive Editor-in-Chief
Peter Proksch
Institute of Pharmaceutical Biology, Heinrich-Heine-University Düsseldorf, Universitätsstr. 1, Geb. 26.23, D-40225 Düsseldorf, Germany. Tel. 0049 (211)-811-4163, Fax 0049 (211)-811-1923,
Received: 22 December 2005 / Published: 22 December 2005
After serving as the Executive Editor-in-Chief for Marine Drugs for almost three years I am now stepping back from this position but will remain attached to the Journal by serving on the Editorial Board. Due to the combined efforts of all members of the Editorial Board, including Dr. Shu-Kun Lin who continues to be the untiring driving force behind the curtain we witnessed the birth of a new Journal that is entirely devoted to the discovery of marine derived drugs or drug candidates. Marine natural products chemistry has grown over the last decades and developed into a fascinating as well as promising field of basic and applied natural sciences including biology, chemistry and pharmacology just to name a few disciplines involved. So far, however, no Journal restricted itself the field of marine drug discovery until Marine Drugs moved in. This new Journal therefore occupies a strategically important niche where it can serve as a platform for all groups interested in the marine field. As for all Journals the success highly depends on the quality of manuscripts submitted. I want to take this opportunity therefore and thank all authors who have submitted their valuable work to Marine Drugs as well as those colleagues that were involved in refereeing the papers. I strongly hope and wish that Marine Drugs will continue to prosper in the future.
Mar. Drugs EISSN 1660-3397 Published by MDPI AG, Basel, Switzerland RSS E-Mail Table of Contents Alert
Back to Top